Skip to main content

May 2016

 

 

academics

 

Clinical research courses

New research has found that a process initiated in white blood cells known as neutrophils may lead to worse outcomes for some patients with chronic obstructive pulmonary disease (COPD). The discovery may help identify patients at higher risk for COPD progression, who might also show little benefit from standard treatments. The study was presented at the ATS 2016 International Conference.

(adsbygoogle = window.adsbygoogle || []).push({});

Pfizer Inc. announced results of two Phase 3 studies demonstrating the immunogenicity of TRUMENBA® (Meningococcal Group B Vaccine) against invasive meningococcal B (MnB) strains representative of prevalent strains in the U.S. and Europe. The two studies, one in adolescents and one in young adults, met all primary immunogenicity endpoints. Also, secondary data presented show that TRUMENBA demonstrated similar immune responses against ten additional MnB strains, in both adolescents and young adults. The data, which continue to support the vaccine’s current safety and tolerability profile, were presented at the 34th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2016).

Piramal Enterprises’ Consumer Products Division has entered into an agreement to acquire four brands from Pfizer Limited for a consideration of Rs 110 crore. The acquisition includes brands namely Ferradol, Neko, Sloan’s and Waterbury’s compound. Additionally the agreement also includes the trademark rights for Ferradol and Waterbury’s compound in Bangladesh and Sri Lanka. These brands hold a rich legacy and have a high consumer pull and are available in India for the past 30+ years.

An international study, conducted by researchers from the Institute for Development Research (IRD), Inserm and Institut Pasteur and their Guinean partners (Donka University Hospital, Macenta Hospital, National Institute of Public Health, and University of Conakry, confirms that Ebola virus persists in the semen of survivors of the epidemic in Guinea, for up to 9 months after their recovery. These results, which recall the importance of monitoring survivors in order to prevent the risks of new epidemic outbreaks, are published in the Journal of Infectious Diseases on 3 May 2016.

Job for MPHW (M) in Office of the CDMO - 25 posts

Applications in the prescribed proforma are invited from eligible candidates for following posts under the Chief District Medical Officer, Cuttack District to be filled on contractual basis with monthly remuneration mentioned against each of the post.

The Candidates must not be below the age of 21 years or above 32 years as on publication of this advertisement. The upper age limit shall be relaxed by 5 years in case of SC & ST. SEBC. Women candidates, and 10 years in case of physically handicapped / Ex- Serviceman candidates. Age relaxation is however applicable in respect of one category only. The ORV Act and Rule will be applicable for these contractual recruitments.

Post: MPHW(M)

Opportunity in Biosafety Support Unit- Government of India as Chief (Bio-pharma)

India Biotechnology Regulations implemented under Rules, 1989 of the Environment Protection Act, 1986 are dynamic and complementing with emerging technologies used for research, product development and progress in science of risk assessment. Government of India has undertaken several reforms in biotechnology regulatory system. To assist Review Committee on Genetic Manipulation (RCGM), a project ”Establishment of Biosafety Support Unit (BSU)” with trained and skilled scientists with specialization in relevant scientific disciplines is being implemented at Regional Centre for Biotechnology. BSU has been assisting in scrutiny of applications received for risk assessment and preparation of reports to facilitate decision making by the competent bodies.

Post: Chief (Bio-pharma)-01

ECHS invites applications from Pharmacists - 11 posts

Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance(Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme(Management Information System) (AFGIS (MIS)) schemes. These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees. Therefore, the requirement was felt of establishing a medicare system which could provide quality medicare to the retirees of the Armed Forces.

Post: Pharmacist-(11) {Danapur-1, Muzzafarpur-1, Hajipur-1, Mothihari-1, Siwan-1, Sitamarhi-1, Bhagalpur-1, Madhubani-1, Samastipur-1, Munger-1, Khagaria-1}

Applications are invited from M.Pharm for Senior Research Fellow post at BHU

Banaras Hindu University ranks among the first few in the country in the field of academic and research output. This university has two campuses, 3 institutes, 16 faculties, 140 departments, 4 advanced centers and 4 interdisciplinary schools. The University is making its mark at the national and international levels in a number of frontier areas of Science, Social Science, Technology, Medicine and Agriculture etc.

Post: Senior Research Fellow